United States Inflammatory Bowel Disease Drugs Sales Market Report 2021

July 2016 | 122 pages | ID: UF01B89BD94EN
QYResearch

Abstracts

This report studies sales (consumption) of Inflammatory Bowel Disease Drugs in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Merck & Company
• Janssen Pharmaceuticals
• Abbvie
• Biogen Idec
• UCB
• Shire
• Pfizer
• Novartis
• Novo Nordisk
• Boehringer Ingelheim
• Salix Pharmaceuticals
• Genentech
• Amgen
• Mitsubishi Tanabe
• Akebia Therapeutics
• Celltrion
• ChemoCentryx
• Ferring Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Inflammatory Bowel Disease Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Inflammatory Bowel Disease Drugs Sales Market Report 2021

1 INFLAMMATORY BOWEL DISEASE DRUGS OVERVIEW

1.1 Product Overview and Scope of Inflammatory Bowel Disease Drugs
1.2 Classification of Inflammatory Bowel Disease Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Applications of Inflammatory Bowel Disease Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size (Value and Volume) of Inflammatory Bowel Disease Drugs (2011-2021)
  1.4.1 USA Inflammatory Bowel Disease Drugs Sales, Revenue and Price (2011-2021)
  1.4.2 USA Inflammatory Bowel Disease Drugs Sales and Growth Rate (2011-2021)
  1.4.3 USA Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2011-2021)

2 USA INFLAMMATORY BOWEL DISEASE DRUGS COMPETITION BY MANUFACTURERS

2.1 USA Inflammatory Bowel Disease Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Inflammatory Bowel Disease Drugs Revenue and Share by Manufactures (2015 and 2016)

3 USA INFLAMMATORY BOWEL DISEASE DRUGS (VOLUME AND VALUE) BY TYPE

3.1 USA Inflammatory Bowel Disease Drugs Sales and Market Share by Type (2011-2021)
3.2 USA Inflammatory Bowel Disease Drugs Revenue and Market Share by Type (2011-2021)

4 USA INFLAMMATORY BOWEL DISEASE DRUGS (VOLUME) BY APPLICATION

5 USA INFLAMMATORY BOWEL DISEASE DRUGS MANUFACTURERS ANALYSIS

5.1 Merck & Company
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Inflammatory Bowel Disease Drugs Product Type and Technology
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Merck & Company (2015 and 2016)
5.2 Janssen Pharmaceuticals
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharmaceuticals Product Type and Technology
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Pharmaceuticals Sales, Revenue, Price of Janssen Pharmaceuticals (2015 and 2016)
5.3 Abbvie
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Abbvie Product Type and Technology
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Abbvie Sales, Revenue, Price of Abbvie (2015 and 2016)
5.4 Biogen Idec
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 Novo Nordisk Product Type and Technology
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Biogen Idec Sales, Revenue, Price of Biogen Idec (2015 and 2016)
5.5 UCB
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 UCB Product Type and Technology
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 UCB Sales, Revenue, Price of UCB (2015 and 2016)
5.6 Shire
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 Shire Product Type and Technology
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Shire Sales, Revenue, Price of Shire (2015 and 2016)
5.7 Pfizer
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 Pfizer Product Type and Technology
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)
5.8 Novartis
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 Novartis Product Type and Technology
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Novartis Sales, Revenue, Price of Novartis (2015 and 2016)
5.9 Novo Nordisk
  5.9.1 Company Basic Information,Manufacturing Base and Competitors
  5.9.2 Novo Nordisk Product Type and Technology
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Novo Nordisk Sales, Revenue, Price of Novo Nordisk (2015 and 2016)
5.10 Boehringer Ingelheim
  5.10.1 Company Basic Information,Manufacturing Base and Competitors
  5.10.2 Boehringer Ingelheim Product Type and Technology
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Boehringer Ingelheim Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)
5.11 Salix Pharmaceuticals
5.12 Genentech
5.13 Amgen
5.14 Mitsubishi Tanabe
5.15 Akebia Therapeutics
5.16 Celltrion
5.17 ChemoCentryx
5.18 Ferring Pharmaceuticals

6 INFLAMMATORY BOWEL DISEASE DRUGS TECHNOLOGY AND DEVELOPMENT TREND

6.1 Inflammatory Bowel Disease Drugs Technology Analysis
6.2 Inflammatory Bowel Disease Drugs Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Inflammatory Bowel Disease Drugs
Table Classification of Inflammatory Bowel Disease Drugs
Figure USA Sales Market Share of Inflammatory Bowel Disease Drugs by Type in 2015
Table Applications of Inflammatory Bowel Disease Drugs
Figure USA Sales Market Share of Inflammatory Bowel Disease Drugs by Application in 2015
Table USA Inflammatory Bowel Disease Drugs Sales, Revenue and Price (2011-2021)
Figure USA Inflammatory Bowel Disease Drugs Sales and Growth Rate (2011-2021)
Figure USA Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2011-2021)
Table USA Inflammatory Bowel Disease Drugs Sales of Key Manufacturers (2015 and 2016)
Table USA Inflammatory Bowel Disease Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Inflammatory Bowel Disease Drugs Sales Share by Manufacturers
Figure 2016 Inflammatory Bowel Disease Drugs Sales Share by Manufacturers
Table USA Inflammatory Bowel Disease Drugs Revenue by Manufacturers (2015 and 2016)
Table USA Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers
Table 2016 USA Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers
Table USA Inflammatory Bowel Disease Drugs Sales and Market Share by Type (2011-2021)
Table USA Inflammatory Bowel Disease Drugs Sales Share by Type (2011-2021)
Figure Sales Market Share of Inflammatory Bowel Disease Drugs by Type (2011-2021)
Figure USA Inflammatory Bowel Disease Drugs Sales Growth Rate by Type (2011-2021)
Table USA Inflammatory Bowel Disease Drugs Revenue and Market Share by Type (2011-2021)
Table USA Inflammatory Bowel Disease Drugs Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Inflammatory Bowel Disease Drugs by Type (2011-2021)
Figure USA Inflammatory Bowel Disease Drugs Revenue Growth Rate by Type (2011-2021)
Table USA Inflammatory Bowel Disease Drugs Sales and Market Share by Application (2011-2021)
Table USA Inflammatory Bowel Disease Drugs Sales Share by Application (2011-2021)
Figure Sales Market Share of Inflammatory Bowel Disease Drugs by Application (2011-2021)
Figure USA Inflammatory Bowel Disease Drugs Sales Growth Rate by Application (2011-2021)
Table Merck & Company Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Merck & Company (2015 and 2016)
Table Janssen Pharmaceuticals Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Janssen Pharmaceuticals (2015 and 2016)
Table Abbvie Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Abbvie (2015 and 2016)
Table Biogen Idec Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Biogen Idec (2015 and 2016)
Table UCB Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of UCB (2015 and 2016)
Table Shire Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Shire (2015 and 2016)
Table Pfizer Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Novartis Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Novartis (2015 and 2016)
Table Novo Nordisk Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Novo Nordisk (2015 and 2016)
Table Boehringer Ingelheim Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)
Table Salix Pharmaceuticals Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Salix Pharmaceuticals (2015 and 2016)
Table Genentech Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Genentech (2015 and 2016)
Table Amgen Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Amgen (2015 and 2016)
Table Mitsubishi Tanabe Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Mitsubishi Tanabe (2015 and 2016)
Table Akebia Therapeutics Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Akebia Therapeutics (2015 and 2016)
Table Celltrion Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Celltrion (2015 and 2016)
Table ChemoCentryx Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of ChemoCentryx (2015 and 2016)
Table Ferring Pharmaceuticals Basic Information List
Table Inflammatory Bowel Disease Drugs Sales, Revenue, Price of Ferring Pharmaceuticals (2015 and 2016)